Food and Drugs Act
Version of section 21.71 from 2019-06-21 to 2020-05-22:
Marginal note:Clinical trials and investigational tests
21.71 The holder of a therapeutic product authorization referred to in paragraph 30(1.2)(c) shall ensure that prescribed information concerning the clinical trial or investigational test is made public within the prescribed time and in the prescribed manner.
- 2014, c. 24, s. 3
- 2019, c. 29, s. 168(F)
Page Details
- Date modified: